Background: While matrix-induced autologous chondrocyte implantation (MACI) has demonstrated encouraging outcomes in the treatment of knee chondral defects, there remains little available research specifically investigating its use in the patellofemoral joint.
biodegradable polymer (HYAFF 11) scaffold, there are only 2 further studies investigating patellofemoral MACI. 17, 33 Furthermore, of the aforementioned studies, only 4 appear to undertake some form of magnetic resonance imaging (MRI)-based assessment. 19, 20, 33, 47 The aim of this study was to prospectively evaluate preand postoperative clinical and radiologic outcome in patients undergoing MACI to address isolated patellofemoral chondral lesions (patella or trochlea). We hypothesized the following: (1) Patients would significantly improve throughout the pre-and postoperative timeline to 24 months in the patient-reported and functional tests employed. (2) Patellofemoral chondral lesions treated with MACI in this cohort would significantly improve throughout the postoperative timeline to 24 months, as assessed via MRI. (3) Significant improvements in clinical and radiologic outcomes would also be observed after group stratification into patients who underwent MACI to the patella or trochlea and those who did or did not undergo concurrent patellofemoral realignment.
METHODS

Participants
Between June 2008 and June 2012, a total of 47 consecutive patients underwent MACI to address symptomatic cartilage defects on the trochlea (n = 23) or patella (n = 24) (Table 1) . Preoperatively, all patients suffered from persistent pain associated with grade III or IV chondral lesions, assessed with the International Cartilage Repair Society chondral defect classification system. 5 Patients were included if they were 18 to 65 years of age and were being treated for isolated patellofemoral chondral defects. Patients were excluded if they had a body mass index . 35 , ligamentous instability, varus/valgus abnormalities (.3°tibiofemoral anatomic angle), or ongoing progressive inflammatory arthritis. There were no patients excluded because of the aforementioned exclusion criteria. Patients provided their written informed consent before study enrollment. This research was approved by the Hollywood Private Hospital (HPH145) and University of Western Australia (RA-4-3-0464) Human Research Ethics Committee.
Of the 47 patients, 27 reported a specific traumatic event (sporting or occupational) that resulted in subsequent knee pain/symptoms. While 11 patients were unable to recollect a traumatic event although reported an onset of pain/symptoms during a specific activity, 9 were unable to recollect any reason for the onset of their pain/symptoms. A total of 28 patients had been treated previously with 1 or more surgical procedures to address knee pain, including arthroscopy (n = 35), anterior cruciate ligament reconstruction (n = 2), extensor realignment (n = 3), lateral release (n = 11), and other procedures (n = 6).
Preoperatively, all patients underwent MRI to evaluate the location, size, and severity of the chondral defect, as well as any other soft tissue damage incorporating the menisci or ligamentous structures. Patients also underwent computed tomography imaging to assess the degree (if any) of patellofemoral knee joint malalignment. Tibial tubercle-trochlear groove (TT-TG) distance was measured on computed tomography, and adjunct tibial tubercle transfer (TTT) was performed with .0.9-cm lateralization of the tibial tuberosity. Of the 47 patients that underwent MACI, 19 underwent concurrent TTT to correct malalignment as per the aforementioned criteria (Table 1) . Patellofemoral alignment was also assessed clinically by the orthopaedic specialist to evaluate patellar tracking, subluxation, lateral retinacular tightness, and Q angle.
Surgical Technique
MACI is a 2-stage technique, where arthroscopic surgery was initially performed to harvest a sample of articular cartilage from a nonweightbearing area of the knee. The cartilage biopsy specimen was then sent to the laboratory (Genzyme), whereby chondrocytes were isolated from the cartilage tissue, cultured for approximately 6 to 8 weeks, and seeded onto a type I/III collagen membrane (ACI-Maix; Matricel GmbH) 3 days before second-stage reimplantation. At the time of second-stage implantation, the chondral defect was prepared via an open arthrotomy by removing all damaged cartilage down to, but not through, subchondral bone. The resultant defect was measured and used to shape the membrane, which was secured to the bone using a thin layer of fibrin glue. The wound was closed after assessment of graft stability. The TT-TG distance on computed tomography indicated .0.9-cm lateralization of the tibial tuberosity in 19 patients; therefore, all 19 underwent concomitant patellofemoral realignment. This was undertaken via a combined lateral patellofemoral retinacular release and anteromedial TTT performed using the Heatley modification 24 of the Fulkerson technique. 14, 15 The tibial tubercle was mediatized and secured with two 3.5-mm cortical screws so that the patella was positioned centrally in the trochlear groove at 20°of knee flexion (from full knee extension). However, posttransfer TT-TG distance was not evaluated. Finally, TTT was performed concurrently with the MACI grafting.
Postoperative Rehabilitation
Immediate postoperative inpatient rehabilitation consisted of the following: continuous passive motion (0°-30°) within 12 to 24 hours after surgery; active dorsi-and plantarflexion of the ankle to encourage lower extremity circulation; isometric contraction of the quadriceps, hamstrings, and gluteal musculature to maintain muscle tone and minimize muscle loss 4, 35 ; cryotherapy to control edema; and teaching of proficient toe-touch ambulation through the affected limb. To protect the repaired cartilage surface, a hinged knee brace was worn postoperatively for up to 24 hours per day, depending on the stage of rehabilitation. After these early postoperative stages, patients participated in a standardized outpatient rehabilitation program over a 12-week period, while further activity guidelines and advice were provided to patients up until 12 months after surgery ( Table 2 ). These protocols were individually modified for each patient depending on the location and size of the defect, any additional surgical procedures that may have been performed, and the presentation of clinical signs throughout the postoperative period reflective of overload, such as pain and swelling.
Clinical Assessment
Several patient-reported outcome (PRO) measures were employed to evaluate patient outcome presurgery and at 3, 12, and 24 months after surgery, including (1) the Knee injury and Osteoarthritis Outcome Score (KOOS) 43 to assess knee pain, symptoms, activities of daily living (ADL), sport and recreation, and knee-related quality of life; (2) the 36-Item Short Form Health Survey (SF-36), which evaluated the general health of the patient, producing mental and physical component scores 1 ; and (3) a visual analog scale to assess the frequency and severity of knee pain on a scale of 0 to 10, with 10 being worst. A patient satisfaction questionnaire was also employed at 24 months after surgery to investigate each patient's level of satisfaction with the MACI surgery overall, as well as his or her satisfaction with MACI in relieving knee pain, improving the ability to perform normal daily activities, and being able to participate in sport.
Functionally, the 6-minute walk test 6, 8, 11, 33, 40 was employed postoperatively to assess the maximum comfortable distance that the patient could walk in a 6-minute period, as were maximal active knee flexion and extension range of motion. Isokinetic strength of the quadriceps and hamstrings muscle groups was assessed using an isokinetic dynamometer (Isosport International) at 12 and 24 months after surgery. Patients were seated in the dynamometer chair so that the hips and knees were in a 90°f lexed position. The trunk and thigh were stabilized using rigid straps, and adjustments were made for thigh and leg length, in accordance with each patient's stature. Concentric knee extension and flexion strength were measured through a range of 0°to 90°of knee flexion, at a single isokinetic angular velocity of 90 deg/s. Each trial consisted of 4 repetitions: 3 low-intensity repetitions of knee extension and flexion, immediately followed by 1 maximal test effort. Two trials on each lower limb were undertaken, alternating between the operated and nonoperated limbs, with the first trial always undertaken on the nonoperated side. Oral encouragement was provided and standardized across all patients and trials. Patients were given adequate rest between trials to minimize fatigue, although this was not standardized but rather based on the patient's individual readiness to proceed. For all knee extension and flexion efforts, the peak torque value (NÁm) was measured, while a limb symmetry index was calculated by dividing the peak values (extension and flexion) on the operated limb by that recorded on the nonoperated limb.
MRI Assessment
Repair tissue was assessed with high-resolution MRI at 3, 12, and 24 months after surgery, using a 1.5-or 3-T clinical scanner (Siemens, Philips, or General Electric). Standardized proton density and T2-weighted fat-saturated images were obtained in coronal and sagittal planes (slice thickness, 3 mm; field of view, 14-15 cm; matrix, 512 in at least 1 axis for proton density images, with minimum 256 matrix in 1 axis for T2-weighted images). Additional axial proton density fat-saturated images were obtained (slice thickness, 3-4 mm; field of view, 14-15 cm; matrix, minimum 224 in at least 1 axis).
For MRI-based scoring, the magnetic resonance observation of cartilage repair tissue (MOCART) scoring system 31, 32 was initially employed to evaluate 8 pertinent parameters of graft repair (signal intensity, graft infill, border integration, surface contour, structure, subchondral lamina, subchondral bone, and effusion). These were selected to best describe the morphologic features and signal intensity of the repair tissue, with each scored individually from 1 to 4 (1 = poor, 2 = fair, 3 = good, 4 = excellent) in comparison with the native cartilage. An MRI composite score was then calculated by multiplying the 8 individual scores by a weighting factor 40 and summing the weighted scores. 7, 40 This composite score also ranged from 1 to 4 (1 = poor, 2 = fair, 3 = good, 4 = excellent). In addition to the MRI composite score, we evaluated graft infill, also scored from 1 to 4 (1 = poor, 2 = fair, 3 = good, 4 = excellent) based on the MOCART classification system. MRI evaluation was performed by an independent musculoskeletal radiologist with almost 10 years of experience with the MOCART scoring system for cartilage repair since its initial publication in 2004.
Data and Statistical Analysis
Descriptive statistics were used to summarize the characteristics of the sample overall and by 4 subgroups according to implant location (patella or trochlea) and whether adjunct TTT was performed. Fisher exact test, 1-way analysis of variance, and Kruskal-Wallis test were used to evaluate differences in sample characteristics across these procedural subgroups. Repeated-measures analysis of variance was used to examine changes in all outcomes over time, including evaluation of both a main effect and an interaction effect with type of procedural group, with models also adjusted for patient sex because of imbalance across the 4 subgroups. For MRI evaluation, the kappa coefficient was used to assess intraobserver reliability for graft infill, while the intraclass correlation coefficient was used for the continuous MRI composite score. This was achieved by rescoring 20 randomly selected MRI images filtered through a second time to the radiologist. Power calculations indicated that 8 patients in each subgroup would give 80% power to detect improvements in outcome from baseline of at least 1 standard deviation at a = 0.05 (within each subgroup). Statistical analysis was performed with Stata/IC version 13.1 for Windows (StataCorp LP).
RESULTS
Of the 47 patients in this prospective follow-up, all cases were reviewed clinically and radiologically preoperatively and at 3 and 24 months after surgery. Two patients (patella, n = 1; trochlea, n = 1) were unavailable at 12month follow-up (an intention-to-treat analysis was performed using the ''last value carried forward'' technique for these 2 cases). Table 1 displays the sample characteristics overall and by 4 subgroups according to implant location and TTT. The only factor that demonstrated statistically significantly imbalance was sex, with more men in groups undergoing trochlear implants.
Patient-Reported Outcome Measures
All PRO measures demonstrated clinically and statistically significant improvements over time (Table 3 ). There was no significant main effect for procedure (P = .221-.925) and no interaction between time and procedure for all outcomes (P = .543-.999), with the exception of pain frequency (P = .024). For the frequency visual analog scale, the group with trochlear implants and no TTT showed a more rapid improvement to 3 months than did the other groups, but they had no better long-term outcome at 12 and 24 months. All procedure groups separately demonstrated clinically and statistically significant improvements in PRO measures. Figure 1 demonstrates all KOOS subscales pre-and postoperatively for patients grouped by procedure type. At 24 months after surgery, 85% (n = 40) of patients were satisfied with the ability of MACI to relieve their knee pain; 87% (n = 41) and 78% (n = 37) were satisfied with the improvement in their ability to undertake daily and recreational activities, respectively; and 62% (n = 29) were satisfied with the improvement in their ability to participate in sport. Overall, 85% (n = 40) of patients were satisfied with the results of their MACI surgery.
Strength and Function Measures
Results on the 6-minute walk test demonstrated statistically and clinically significant improvement over time (Table 4) , with no evidence of a main effect for procedure group (P = .936) or interaction between procedure group and time (P = .940) ( Figure 2 ). All procedure groups separately demonstrated clinically and statistically significant improvements in the 6-minute walk test. Knee extension range of motion improved significantly over time (Table 4) , with no evidence of a main effect for procedure group (P = .936). A significant time-group interaction (P = .023) existed owing to a slightly higher improvement in those patients with trochlear grafts and adjunct TTT in 12 to 24 months related to 3 to 12 months. Flexion range of motion also improved significantly over time (Table 4) , with no evidence of a main effect for procedure group (P = .670) or time-group interaction (P = .571). Both peak extension and flexion torque improved significantly from 12 to 24 months (Table 4) , with no evidence of a main effect for procedure group (P = .321 and 0.290, respectively) or time-group interaction (P = .994 and 0.510, respectively) ( Table 4 ). The limb symmetry index for knee extension torque indicated a postoperative strength deficit with no significant improvement over 12 to 24 months, whereas the mean limb symmetry index for flexion torque at 24 months was 1.01 (Table 4 ).
MRI Results
Evaluation of intraobserver reliability indicated perfect agreement for graft infill (k = 1.00) and an intraclass correlation coefficient for the MRI composite score of 0.996 (95% CI, 0.991-0.999) for the 20 randomly selected image pairs.
The MRI composite score demonstrated a statistically significant improvement over time (Table 4) , with no evidence of a main effect for procedure group (P = .405) or interaction between procedure group and time (P = .899) ( Figure 3 ). Graft infill demonstrated a statistically significant improvement over time (Table 4) , with no evidence of a main effect for procedure group (P = .502) or interaction between procedure group and time (P = .956). At 24 months after surgery, 40.4% (n = 19) of patients exhibited complete graft infill comparable with the adjacent native cartilage, with a further 6.4% (n = 3) demonstrating a hypertrophic graft. A further 31.9% (n = 15) of patients exhibited 50% to 100% tissue infill, therefore making a combined 78.7% (n = 37) with infill .50% at 24 months. Therefore, 17% (n = 8) of patients exhibited \50% tissue infill, and as reported below in the complications section, 2 patients (4.3%) demonstrated graft failure (exposed subchondral bone). The MRI scans (3, 12 , and 24 months after surgery) of an asymptomatic patient at 24 months are shown in Figure 4 . 
Complications and Failures
The incidence of graft hypertrophy was observed on MRI in 2 patients (4.3%) at 3-and 12-month follow-up and in 3 patients (6.4%) at 24-month follow-up. All 3 cases remained asymptomatic at 24 months. One patient in this group developed a deep vein thrombosis in the early postoperative stages, was treated accordingly, and recovered without sequelae. There were 2 graft failures (out of 47 patients), determined via graft delamination and/or exposed subchondral bone on MRI. One patient was devoid of repair tissue at 3 months, which remained on MRI at 12 and 24 months. The second patient exhibited exposed subchondral bone at 24 months after surgery, despite scores of 3.0 and 2.85 for graft infill and the MRI composite score, respectively, at 12 months after surgery ( Figure 5 ).
DISCUSSION
While MACI has demonstrated encouraging outcomes in the treatment of articular cartilage defects in the knee, 2, 3, 11, 16 there remains a paucity of prospective research specifically investigating its successful use in the patellofemoral joint. We undertook a prospective clinical and radiologic follow-up to 2 years in patients after MACI to address symptomatic cartilage defects on the patella or trochlea, with and without concurrent patellofemoral malalignment. A significant improvement was observed over the 2-year period in all of PRO measures. An expected decline in the KOOS sport and recreation subscale was seen from the point before surgery to 3-month follow-up because of the physical limitations imposed on patients at this early postoperative time to minimize the risk of early graft failure. 22, 41 Of the studies investigating MACI in the patellofemoral joint, only Meyerkort et al 33 employed the KOOS and SF-36, with 24-month outcomes in this study comparable with those results. Pascual-Garrido et al 39 reported improved postoperative KOOS scores at a mean follow-up of 4 years in patients after periosteal-covered ACI in the patellofemoral joint, although the results for all subscales appear better in this cohort at 24 months. Several other studies investigating a variety of ACI methods performed in the patellofemoral joint reported improved clinical outcomes up until (and beyond) 24 months, although these did not employ the KOOS and SF-36 scoring tools. [17] [18] [19] [20] [21] 29, 30, 36, 48 Patients demonstrated a significant improvement over the postoperative timeline for the 6-minute walk test and active knee flexion and extension, with the primary improvement occurring between 3 and 12 months as expected. While the 6-minute walk test has been reported as a foundation for functional independence and an important component of many activities of normal daily living, 40 it may be argued that it is not a validated measure in MACI patients, nor is walking on level terrain at pace an activity that significantly troubles patients with patellofemoral symptoms. Nevertheless, we employ this assessment routinely through our clinical practice. The 6-minute walk test outcomes in this study are comparable with other research. 8, 11 While peak knee flexor strength was not significantly different between the operated and nonoperated limbs throughout the postoperative timeline and, in fact, higher on the operated limb at 12 and 24 months, knee extensor deficiencies were observed. While it is evident that peak knee extensor strength improved significantly over the postoperative timeline in the operated limb, it still remained significantly lower than the nonoperated side at 12 and 24 months. Prior research demonstrated a reduced knee strength profile even at 4 to 5 years after ACI surgery, 9, 28, 36 with Muller et al 36 reporting greater strength deficiencies in patients undergoing patellofemoral (versus tibiofemoral) ACI, particularly in knee extensor strength. They suggested as a reason for this the more invasive arthrotomy required with subsequent elevation of the patella as compared with performing ACI for defects on the femoral condyles. While we did not look to compare our patellofemoral MACI cohort with a MACI group undergoing MACI on the weightbearing femoral condyles, the knee extensor strength deficits in the operated limb at 12 and 24 months were clear.
Graft infill and the MRI composite score improved significantly throughout the postoperative time line. At 24 months, 46.8% of patients exhibited complete or hypertrophic tissue infill, with a total of 78.7% of patients with infill .50%. While only a few studies that investigated ACI in the patellofemoral joint undertook some form of MRI-based assessment, 19, 20, 33, 47 our results appear comparable with the limited research available. Meyerkort et al 33 to whether MACI was performed on the patella or trochlea and with or without adjunct patellofemoral realignment. It appears that the limited studies available investigating ACI/MACI in the patellofemoral joint tended to evaluate the patient cohort overall, without any statistical analysis after group stratification based on graft location. However, in contrast to our results, a recent publication demonstrated significantly better outcomes in trochlear lesions when compared with the patella after matrix-assisted ACI. 13 The difference in outcomes remains unknown, and more research is clearly required given that, anecdotally, we have generally found trochlear lesions to be more forgiving than patellar lesions, irrespective of the cartilage repair method employed. This was not reflected in our clinical results, with both groups producing similar outcomes. Early reported results of ACI in the patellofemoral joint were poor since patellofemoral malalignment was not addressed before or at the time of chondral grafting. 4 It has been demonstrated that patients undergoing ACI in the patellofemoral joint perform better after concomitant proximal and distal realignment surgery, 26, 39 even in the absence of patellofemoral malalignment, 26 and a recent review highlighted the significant clinical improvement in patients undergoing ACI with concomitant realignment. 46 This is contrary to our results, as well as those of others who demonstrated equivocal outcomes in patients with normal patellofemoral alignment versus those undergoing concurrent TTT for malalignment. 33, 48 Note that TTT was performed in this series only if malalignment was present. Therefore, while we do not evaluate posttransfer TT-TG distance routinely, we did assume that all patients had normal alignment at the time of MACI surgery and after. This was the rationale for our third hypothesis, in that a similar progression of pain, symptoms, and function would exist in patients who did or did not undergo adjunct TTT at the time of MACI surgery. A number of limitations exist within the present study. First, we employed the KOOS, SF-36, and visual analog scale as PRO measures in this study, as we employ routinely through our institution for chondrocyte implantation. 1, 10, 31, 38, 40 As outlined by Hambly and Griva, 23 there is currently no agreement on a gold standard PRO measure for the evaluation of cartilage repair surgery, let alone ACI, although certainly the KOOS is recommended for use with cartilage repair patients. 42 However, we acknowledge that other PRO scores-including the International Knee Documentation Committee subjective knee form, Cincinnati Knee Rating System, Lysholm score, and Tegner activity scale-have been used in other studies reporting on ACI in the patellofemoral joint. [17] [18] [19] [20] [21] 29, 30, 36, 48 Furthermore, we employed the 6-minute walk test as a basic measure of function, and while this test has been used in ACI patients, 6, 8, 11, 33, 40 to the best of our knowledge it has not been validated.
Second, we employed the MOCART scoring system to evaluate the grafts via MRI and MRI composite score. We acknowledge that the MOCART scoring tool has not been validated against arthroscopic or histologic repair tissue findings and that there are indeed other emerging imaging methods for assessing the biochemical characteristics of repair tissue, including dGEMRIC (delayed gadolinium-enhanced MRI of cartilage) and T2 mapping. 27, 44, 45 However, we must acknowledge that there is currently a relative paucity of studies evaluating patellofemoral MACI with any form of MRI-based assessment. We also acknowledge that there was no histologic analysis provided in this study, although this was unwarranted since there have been no second-look arthroscopies and associated tissue biopsies required at this time.
This study demonstrated that MACI produced improved clinical outcomes and functional tissue infill to 24 months in patients with full-thickness cartilage defects in the patella or trochlea, supporting our first 2 hypotheses. Our third hypothesis was also supported, whereby we observed significant improvements in all clinical and radiologic outcomes for the 4 subgroupings based on whether MACI was performed on the patella or trochlea and whether concurrent patellofemoral realignment was needed. Although the availability of clinical and MRIbased assessment after MACI in the patellofemoral joint is limited, this research suggests that MACI does provide a suitable treatment option for cartilage defects in the knee, at least up until 24 months after surgery. Longterm follow-up (5-10 years and beyond) is essential to confirm whether the repair tissue produced has the durability required and, if so, whether a durable tissue is reflected in clinical outcome and patient quality of life.
